{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:20:30Z","timestamp":1773832830143,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jcrc.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T23:55:31Z","timestamp":1368575731000},"page":"577-585","source":"Crossref","is-referenced-by-count":6,"title":["Procollagen type III aminoterminal propeptide as biomarker of host response in severe sepsis"],"prefix":"10.1016","volume":"28","author":[{"given":"Spyros","family":"Zakynthinos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros","family":"Mentzelopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangellia","family":"Konstandelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Psachoulia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonis","family":"Mavrommatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2013.04.004_bb0005","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0015","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/CCM.0b013e31819d5db1","article-title":"Predisposition, insult\/infection, response, and organ dysfunction: a new model for staging severe sepsis","volume":"37","author":"Rubulotta","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","article-title":"Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis","volume":"164","author":"Harbarth","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0030","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1007\/s001340051134","article-title":"Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock","volume":"26","author":"Brunkhorst","year":"2000","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/infdis\/172.1.296","article-title":"Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity","volume":"172","author":"Gardlund","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0040","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1097\/00003246-200007000-00028","article-title":"Plasma granulocyte-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality","volume":"28","author":"Presneill","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0045","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-0037-1616084","article-title":"Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients","volume":"86","author":"Raaphorst","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0050","first-page":"585","article-title":"Sepsis: a follow-up of cytokine production in different phases of septic patients","volume":"11","author":"Martins","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1521-6616(02)00025-6","article-title":"Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection","volume":"106","author":"Groeneveld","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0060","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1183\/09031936.96.09122650","article-title":"The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment","volume":"9","author":"Meduri","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0065","first-page":"308","article-title":"Circulating extracellular matrix components as markers for connective tissue response to inflammation","volume":"37","author":"Horslev-Petersen","year":"1990","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1749-6632.1985.tb51167.x","article-title":"Post-translational processing of procollagens","volume":"460","author":"Kivirikko","year":"1985","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0075","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/thx.39.10.726","article-title":"Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance","volume":"39","author":"Kirk","year":"1984","journal-title":"Thorax"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1164\/ajrccm\/142.5.1079","article-title":"Determination of serum concentrations of type III procollagen peptide in mechanically ventilated patients: pronounced augmented concentrations in the adult respiratory distress syndrome","volume":"142","author":"Entzian","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00003246-199302000-00016","article-title":"Increased serum concentrations of procollagen type III peptide in severely injured patients: an indicator of fibrosing activity?","volume":"21","author":"Waydhas","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0090","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc7780","article-title":"Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients","volume":"13","author":"Gaddnas","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0095","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1164\/ajrccm.158.5.9801107","article-title":"Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment","volume":"158","author":"Meduri","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0100","first-page":"805","article-title":"The prognostic value of extracellular matrix component concentrations in serum during treatment of adult respiratory distress syndrome with extracorporeal CO2 removal","volume":"29","author":"Kropf","year":"1991","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-122-1-199501010-00003","article-title":"Type III procollagen peptide in the adult respiratory distress syndrome: association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death","volume":"122","author":"Clark","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/ajrccm.156.3.9701124","article-title":"Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance","volume":"156","author":"Chesnutt","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0115","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1164\/ajrccm.162.5.2001061","article-title":"Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome","volume":"162","author":"Marshall","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0120","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European consensus conference on ARDS. Definition, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0125","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0130","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/00003246-199510000-00007","article-title":"Multiple Organ Dysfunction Score. A reliable descriptor of a complex clinical outcome","volume":"23","author":"Marshall","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0135","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0140","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1186\/cc11868","article-title":"Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome","volume":"16","author":"Sakr","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0145","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00003246-200004000-00011","article-title":"Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit","volume":"28","author":"Muller","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2362.1996.135267.x","article-title":"Increased serum concentrations of the carboxy-terminal cross-linked telopeptide of collagen type I in patients with Gram-negative septicaemia","volume":"26","author":"Wenisch","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8278(03)00184-3","article-title":"Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease","volume":"39","author":"N\u00f8jgaard","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0170","first-page":"77","article-title":"Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects","volume":"22","author":"Risteli","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0168-8278(88)80025-4","article-title":"Is the aminoterminal propeptide of type III procollagen degraded in the liver? A study of type III procollagen peptide in serum during liver transplantation in pigs","volume":"6","author":"Bentsen","year":"1988","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0180","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000185198","article-title":"Increased procollagen III production in patients with kidney disease","volume":"50","author":"Keller","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1213\/ANE.0b013e3181e1db48","article-title":"Skin collagen synthesis is depressed in patients with severe sepsis","volume":"111","author":"Gaddnas","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0190","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1097\/CCM.0b013e3181a02afc","article-title":"Biomarkers of sepsis","volume":"37","author":"Marshall","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0195","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1538-7836.2004.00955.x","article-title":"Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with and without overt disseminated intravascular coagulation","volume":"2","author":"Dhainaut","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jcrc.2013.04.004_bb0200","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/cc2195","article-title":"The PIRO concept: R is for response","volume":"7","author":"Gerlach","year":"2003","journal-title":"Crit Care"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944113001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944113001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T16:44:37Z","timestamp":1563036277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944113001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0883944113001111"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2013.04.004","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}